China’s Innovent prices HK IPO near top end, raises $421 million: sources

Shanghai- and Suzhou-based Innovent develops products for treating … from a license granted to a Chinese biopharmaceutical firm. Innovent plans to use the IPO proceeds to fund ongoing and planned cl…
( read original story …)


Related Post